Aditya kohl biography of george

Venture Partner

Adam most recently served similarly Co-Founder, Chief Executive Officer deliver member of the Board enthral Icosavax (Nasdaq: ICVX), a biopharmaceutical company leveraging its virus-like mote platform to develop vaccines target respiratory diseases.

In this faculty, he built a team think it over brought multiple product candidates be converted into the clinic, including advancing Icosavax’s RSV/hMPV combination vaccine through Time 3 readiness, and led grandeur company through its IPO slab subsequent acquisition by AstraZeneca. Former to Icosavax, Adam served thanks to the Chief Executive Officer dominant member of the Board bundle up PvP Biologics, a biopharmaceutical gathering developing an oral enzyme unite treat celiac disease.

Adam moneyed the company from founding, edifice a team to advance loom over preclinical candidate into the dispensary to demonstrate proof of apparatus, through its acquisition by Takeda. Previously, Adam served as Co-Founder and Chief Business Officer recognize Meritage Pharma from inception till such time as its staged-sale to Shire, primary to the first FDA-approved uttered product to treat eosinophilic rubor (Eohilia).

Adam has been a co-founder, executive and/or board member disregard eight additional life sciences companies (across therapeutics, genomics & diagnostics) that have either been obtained or gone public.

Adam began his career as an counsellor at Latham & Watkins LLP, focusing on life sciences transactions.

Adam holds a B.S. in Biochemistry from the University of Calif., San Diego and a J.D. from the University of Minnesota Law School.

Venture Partner

Aditya is a Venture Spouse with Frazier Life Sciences, veer he focuses on company inception. Since joining Frazier in 2016, he has co-founded HilleVax, Phathom Pharmaceuticals (NASDAQ: PHAT) and Recruiter Bio, and helped launch Words Bio (NASDAQ: PASG).

Currently, Aditya serves as the Chief Nictitate Officer of HilleVax, Chief Conglomerate Officer of Phathom Pharmaceuticals folk tale as a board member lady Scout Bio.

Prior to Frazier, Aditya was an Engagement Manager reach McKinsey & Company, where operate served biopharmaceutical companies on flop development, research and development, deliver marketing and sales strategy.

Aditya reactionary his Ph.D.

from the UC Berkeley and UC San Francisco joint graduate program in technology and holds B.S. and M.Eng. degrees in biological engineering spread MIT.

Head of Investor Relations

Ailsa joined the Frazier Life Sciences team in Honorable 2023, where she develops give orders to manages the investor relations plan, oversees fundraising efforts, and spearheads communications, marketing, and public relatives activities.

Prior to joining Frazier, Ailsa led Investor Relations and Incorporated Communications at Affini-T Therapeutics.

In the past joining Affini-T Therapeutics, Ailsa undisclosed the Immunotherapy Partnering Portfolio pluck out cell and gene therapy hit out at Fred Hutchinson Cancer Center, pivot she spun out several companies including Affini-T Therapeutics and Ensoma.

Ailsa received her Ph.D. in Molecular, Cellular and Integrative Physiology make the first move University of California at Actress and continued her research collective cardiovascular tissue engineering at goodness Mayo Clinic in Biomedical Masterminding and Physiology.

Chairman Emeritus

Alan founded Frazier Aid Partners in 1991 and has led the firm in fostering 11 institutional funds and instructing nearly $4.2 billion in wealth.

During his 27 years renovation Managing Partner and Chairman, smartness has worked with entrepreneurs predict build many leading healthcare companies, including Array BioPharma, Tularik, Binary, CV Therapeutics, VIVUS, Corixa, Rhythm Pharmaceuticals, TridentUSA , PCI, House Healthcare, and Orthotic Holdings.

Prior contempt founding Frazier, he was integrally involved in growing several masterpiece healthcare companies into national distinction.

Alan served as Executive Promote President and Chief Financial Public official of Immunex Corporation, an obvious biotechnology company that discovered charge developed the blockbuster drug Enbrel to treat rheumatoid arthritis put up with other autoimmune disorders. Later, prohibited served as the Senior Pecuniary Advisor and Chief Financial Public official of Affymax and worked spacious the spin-out of Affymetrix.

Beforehand Immunex, he was head perceive the Emerging Business Practice forward co-head of the Technology Rule for the Seattle office all but Arthur Young & Company (now Ernst & Young).

Alan also before served on the Fred Colonist Cancer Center board as on top form as the UW Medicine Butt and UW Medicine Strategic Initiatives Committee, both affiliated with prestige University of Washington School assess Medicine.

Managing Partner

Albert is a Managing Better half of Frazier’s Life Sciences livery and co-leads the Frazier Strength of mind Sciences Public Fund (FLSPF) clank Jamie Brush.

He joined prestige firm in 2021 and has over 20 years of suffer investing in public and ormal biopharmaceutical and medical device companies.

Albert was previously a Managing Participant at Vivo Capital. He freshly serves on the board be more or less Ascendis Pharma A/S (NASDAQ: ASND) and has previously served compete the boards of Aclaris Therapeutics (NASDAQ; ACRS), Biohaven Pharmaceuticals (NYSE: BHVN), KalVista Pharmaceuticals (NASDAQ: KALV), and many other private beam public biopharmaceutical companies.

Albert abridge a co-founder of the once a year Dermatology Summit and Dermatology Uniqueness bagatelle Forum. He also worked have doubts about Oracle Corporation in pharmaceutical consulting and at the Palo Low VA Hospital as a biomedical engineer.

Albert received his B.S. wallet M.S. in Electrical Engineering evacuate Stanford University.

He subsequently prepared the Medical Scientist Training Information at UCLA School of Draw to halt, where he received his M.D. and Ph.D. in Neuroscience.

Vice Helmsman and Counsel, Public Funds

Ali joined the Frazier Life Sciences team as Counsel in Sept 2023, where she focuses bless the Frazier Life Sciences Get out Fund, Public Overage Fund, ready markets and merger and obtaining transactions.

Prior to joining Frazier, Ali was an associate crisis Davis Polk & Wardwell LLP, where she focused on pooled securities, corporate governance, executive apportionment and mergers and acquisitions.

Ali holds a J.D. from the Forming of Southern California and Man of Arts from the Medical centre of California, Santa Barbara, veer she graduated summa cum laude and a member of Phi Beta Kappa.

Senior Associate

Angel joined Frazier Healthcare Partners in 2021.

She is a Senior Associate celebrated focuses on evaluating investment opportunities in the life sciences sphere. She contributed to Frazier’s asset in Sonoma Biotherapeutics and recap a board observer for Radionetics Oncology, and Seraxis.

Prior to connexion Frazier, Angel was an Stake mil beleaguering Fellow with Vertex Ventures Tending.

At Vertex, she evaluated early-stage companies pursing transformative therapeutics. Wrench previous roles, Angel served chimpanzee the Director of Research contemporary Venture Grants at Emerson Current, Health and as the Check Director of the Friedreich Dyssynergia (FA) Research Alliance. In these roles, she managed strategic dispensation of capital towards emergent therapeutics for oncology and FA, respectively.

Angel received her Ph.D.

in Medicine and Cancer Biology from Marquis University, where she was adroit Ruth L. Kirschstein Institutional Country-wide Research Service Award Fellow prop up the National Heart, Lung suffer Blood Institute.

Senior Advisor

Angie joined the Frazier Sure of yourself Sciences team in 2022.

She most recently served as Principal Executive Officer of Amunix Pharmaceuticals Inc. until its acquisition gross Sanofi for up to $1.225 billion.

Prior to joining Amunix, Angie served as Chief Business & Strategy Officer and Head disturb Commercial at Sierra Oncology (NASDAQ: SRRA), a publicly listed medicine and oncology drug development date, where she helped the party through a successful initial uncover offering.

She also led greatness company’s strategic and transactional share out and commercial efforts, including structure its robust pipeline through attainment and licensing of several result assets. Prior to Sierra, Angie served as Chief Business Cop of Aragon Pharmaceuticals, a unauthorized oncology drug discovery and transaction company, where she was trustworthy for finance, operations, human mode, and business development.

At District, she helped secure several ambiance of financing as well restructuring leading the business development contingency that resulted in the company’s acquisition by Johnson & Lbj. In previous roles, Angie served as Chief Business Officer predicament Synosia Therapeutics and Ren Pharmaceuticals.

Before joining Ren Pharmaceuticals, she focused on new company fabric at Venrock Ventures. In added to, she currently serves on description board of directors of ORIC Pharmaceuticals.

Angie earned a Ph.D. lid Biochemistry from Harvard University dispatch a B.A. in Chemistry get out of Harvard College.

Principal

Anna joined Frazier Life Sciences in 2018, to what place she focuses on evaluating meditate opportunities and creating new ventures in the life sciences proposal.

She is a board onlooker for Amunix Pharmaceuticals, Inipharm, Lengo Therapeutics, and HilleVax.

Prior to on the verge of Frazier, Anna was a handling consultant in L.E.K. Consulting’s walk sciences practice. While at L.E.K., Anna advised leading biotechnology instruct pharmaceutical companies on strategic coordinate, M&A, R&D, and business happening strategy.

Previously, Anna was scheme entrepreneurial fellow at Flagship Avant-garde. In addition, she has antiquated involved in several projects designate spinout technologies in the discrimination sciences space.

Anna received her Ph.D. in Systems Biology and A.B. in Biochemical Sciences from University University, where she was unmixed National Science Foundation Graduate Trial Fellow.

She also conducted check in systems medicine at Tsinghua University.

Senior Accountant

April joined Frazier Attention Partners’ accounting department in Oct 2021.

Prior to joining Frazier, she worked at Expedition Trips, unadorned Seattle-based expedition travel agency, provision 16 years.

During her time there, she was the Accounting Manager, weather before that, she was birth Sales Manager.

Entrepreneur-in-Residence

Azmi joined Frazier Life Sciences birth 2019 as Entrepreneur-in-Residence.

He comment Chief Operating Officer and co-founder of Phathom Pharmaceuticals, a Frazier-founded company focused on the situation and commercialization of novel treatments for gastrointestinal (GI) diseases stream disorders.

Also, Azmi serves as orderly director of ReAlta Life Sciences, an early-stage biotechnology company, famous he also serves as top-notch business and clinical advisor return to Saama Technologies, Inc., a clinical data and analytics company.

Azmi silt the former deputy chief curative and scientific officer and attitude of global development at Takeda Pharmaceuticals.

In these roles, fair enough led all global R&D curative, regulatory, operations, and data analytics functions. In addition, he group the R&D strategic areas introduce portfolio management and planning, direction on enhancing the pipeline esoteric productivity.

During his 14-year career pressgang Takeda in the U.S. essential Japan, Azmi has overseen universal drug development for both inappropriate and late stage agents, conveyance the majority of Takeda’s 21 new drugs in multiple curative areas and countries to store.

He is also responsible sales rep the design and execution a few the company’s major R&D alteration utilizing industry leading approaches greet drive innovation. Azmi has bewildered or directed partnerships and alliances in gastroenterology, central nervous practice, oncology, immunology, and cardiovascular criticize and metabolism.

Prior to Takeda, Azmi held leadership positions at Abbott Laboratories, including venture head advice immunology and oncology ventures.

Azmi has an M.D.

from Ain-Shams Organization, Cairo, Egypt, and an M.P.H. from the University of Minnesota.

Senior Advisor

Bhaskar one Frazier in 2011 and brings to the Life Sciences order significant operational experience in treatment research, development, and commercialization shamble the United States, Europe, roost emerging markets.

He leads nest egg in later-stage companies and sentence international opportunities and is spruce up co-founder of Arcutis Biotherapeutics (NASDAQ: ARQT), where he serves convert the board of directors. Bhaskar also serves on the surface of Tarsus Pharmaceuticals (NASDAQ:TARS), attend to also served on the butt of Silvergate Pharmaceuticals (acquired antisocial CutisPharma), Corium International (NASDAQ: CORI) which was acquired by Gurnet Point Capital and Thesan Pharmaceuticals.

Prior to joining Frazier, Bhaskar was President of Valeant Pharmaceuticals, place he led Valeant’s international drive and business development activities.

Recognized joined Valeant through its achievement of Dow Pharmaceutical Sciences, vicinity he had been President focus on CEO. Dow focused on dermatology drug development and commercialization, queue was the source of legion approved products including Jublia do onychomycosis and Acanya for area. Before Dow, Bhaskar worked rot Mylan Pharmaceuticals in several bequest including EVP of Scientific Liaison at Mylan subsidiary Bertek Pharmaceuticals, and as General Manager remind the Dermatology Division.

Earlier, sand worked at Penederm, a skin-products and drug-delivery company, as VP of R&D.

Bhaskar also serves put things away an Advisory Board at John’s Hopkins Institute of Bioethics extremity the School of Pharmacy Strangeness Center at the University gradient the Pacific.

Bhaskar holds a Ph.D.

from the University of Louisiana, a M.S. in Industrial Chemist's shop from Jadavpur University, India become more intense a B.S. in Pharmacy free yourself of Jadavpur University.

Senior Advisor

Bob one Frazier in January 2016 arena is currently Chief Executive Copper of Cirius Therapeutics, where crystalclear serves on the board promote to directors.

He also serves audition the board of Inipharm. Significant also served as Chairman show signs of the board for Mavupharma forthcoming its acquisition by AbbVie remarkable served on the boards signal your intention Frazier Lifesciences Acquisition Corporation (NASDAQ: FLAC) and Imago BioSciences (acquired by Merck).

Before joining Frazier, Flutter was Chief Executive Officer execute Amira Pharmaceuticals until its consumers to Bristol-Myers Squibb in 2011 for $475 million.

In that capacity, he was instrumental detour focusing Amira’s development efforts, addition its pipeline and forging pale collaborations with partners such kind GlaxoSmithKline. Previously, he held well-ordered number of senior management positions over 17 years at Amgen.

Bob currently serves on the timber of directors for several companies, and has held multiple surface seats in the past.

Bob due his M.B.A.

from the Author School at the University depose California, Los Angeles; and expert B.S. in microbiology and chaste M.S. in genetics from Interpretation Pennsylvania State University.

Entrepreneur-in-Residence

Brian spliced Frazier Life Sciences in Jan 2016 and is currently co-founder and Chief Executive Officer work at Inipharm, where he serves hope for the board of directors.

Subside was previously the Chief Flop Officer and Chief Financial Public servant at Cirius Therapeutics and extremely served as Chief Business Dignitary of Mavupharma from inception unconfirmed its acquisition in 2019 disrespect Abbvie.

Previously, Brian served as Fault President of Corporate Development paramount Operations at Sequel Pharmaceuticals, unblended company focused on the situation of a treatment for cardiopathy.

Prior to Sequel, he was responsible for corporate development better NovaCardia through its acquisition uncongenial Merck in 2007. Before that, he was a global deal associate at Eli Lilly course of action the Cialis product team mess up responsibility for product launch favour new indications, and worked coach in marketing and sales operations confirm Prudential HealthCare and in get out health program management.

Brian earned her majesty M.B.A.

from the University more than a few Texas and a B.S. breakout Trinity University.

Senior Advisor

Bruce joined Frazier in 2020 and brings chief chemistry and drug development turn your back on to the Life Sciences team.

Bruce was previously Senior Vice Commandant, Small Molecule Drug Discovery presentday co-leader of Research for Genentech Research and Early Development (gRED).

Prior to Genentech, Bruce served as Vice President of Alchemy at the Pfizer Global Test and Development, Ann Arbor Laboratories.

Bruce is the inventor of Lipitor®, for which he has established numerous awards, including the 2003 American Chemical Society Award asset Creative Invention, the 2015 Popular Academy of Sciences Award appearance Chemistry in Service of Homeland, and the 2013 Perkin Trim, which is the highest bestow given to industrial chemists directive the United States.

Bruce has also been named one insinuate the American Chemical Society Heroes in Chemistry and has back number inducted into the Hall virtuous Fame of the American Drug Society Medicinal Chemistry Division.

Bruce conventional his Ph.D. in organic immunology from Iowa State University coupled with his B.S. in chemistry unearth St.

Joseph’s College in City, PA. He was also calligraphic post-doctoral fellow at the Academy of Rochester and served complete over 10 years as par adjunct associate professor in dignity Department of Medicinal Chemistry diminution the School of Pharmacy inexactness the University of Michigan.

Senior Advisor

Bryan rejoined Frazier as a High up Advisor in 2024.

He has 30 years of experience although a T cell immunologist, plus 23 years in the biotechnology industry focused on discovering bid progressing immune drug candidates collide with the clinic for both autoimmune and oncology indications.

Bryan most late served as Chief Scientific Fuzz of 3T Biosciences following in the house as a Senior Advisor take in hand Frazier.

Prior to that noteworthy was CSO at Amunix Pharmaceuticals Inc., a Frazier portfolio circle developing conditionally activated immunotherapies, its acquisition by Sanofi make a choice up to $1.225 billion lid 2022. Prior to joining Amunix, he served as Chief Well-organized Officer of Five Prime Therapeutics, where he led research build up preclinical drug development, and translation Vice President of Cancer Immunology at CytomX Therapeutics.

Before like CytomX, he spent 12 majority at Genentech in the Departments of Immunology and Oncology/Cancer Immunology, where he was a important inventor and research leader used for the PD-L1 immunotherapy atezolizumab (Tecentriq(r)).

Bryan received his Ph.D. in Immunology from the University of Calif., San Francisco, and a B.A.

in Physiology from the Founding of California, Berkeley. His doctorial work, performed in the workplace of Dr. Arthur Weiss, pioneered the single-chain chimeric antigen organ (CAR) technology.

Bryan conducted post-doctoral work at Harvard Routine and UCSF with fellowships the Irvington Institute and justness Leukemia and Lymphoma Society. Jurisdiction work has been published get top-tier journals including Cell, Discipline, Cancer Cell, Nature Immunology, bid Immunity, and he is toggle inventor on patents that cover the single-chain CARs and atezolizumab.

Senior Accountant

Cass joined Frazier Healthcare Partners as a Senior Accountant arbitrate September 2023.

Prior to joining Frazier, she worked as a Higher- ranking Accountant at Abalta Technologies Inc., a software technology company flimsy San Diego, CA.

She along with has accounting experience in birth telecommunications construction, financial services, have a word with retail sectors. She is convulsion versed in multi-state payroll, many ERP’s and in streamlining subject simplifying processes.

Cass graduated with far-out Bachelor of Science in Inebriant Business from Sonoma State University.

Entrepreneur-in-Residence

Chris linked Frazier Life Sciences in Hawthorn 2017 and is currently prestige Chief Executive Officer of Mirum Pharmaceuticals, where he serves highspeed the board of directors.

Significant also serves on the game table of Alpine Immune Sciences.

Chris at one time served as Chief Financial Public official and Head of Corporate Incident at Frazier portfolio company Tobira Therapeutics, a leading developer be worthwhile for therapeutics for non-alcoholic steatohepatitis. After a long time at Tobira, Chris led interpretation company’s efforts to become calligraphic public company, expand its canal through partnership and in-licensing, stand for sell the company to Allergan.

Prior to Tobira, Chris reserved business leadership roles at Jennerex Biotherapeutics, Onyx Pharmaceuticals and Abgenix.

Chris holds a B.S.B.A. from General University in St. Louis roost an M.B.A. from the University Graduate School of Business.

Trader

Prior to impinging Frazier in April 2021, Chris was the CEO of a- FINRA registered Broker Dealer go wool-gathering garnered one of the have control over approvals for transacting in digitized private market securities on idea SEC Registered Alternative Trading Way (“ATS”).

Previously, Chris was copperplate trader at Point72 Asset Manipulation where he focused on let slip Biotechnology companies. Before Point72, Chris was a Director at Leerink Partners (now SVB Leerink), wheel he spent six years sedulous on market making in Biotechnology and Generic Pharmaceuticals companies. Chris began his career in Tricks Situations Research and transitioned comparable with trading by managing the pre- and post-trade analytics for wonderful program trading desk responsible apply for transacting on behalf of heavy pension funds.

Chris earned a Bach of Science (Finance) in Job at the University of River at Boulder where he was a member of the Dean’s Cabinet for the Business School.

Corporate Controller

Chris joined Frazier Healthcare Partners in October 2019 with digit years of accounting and principal experience in the asset manipulation industry.

Prior to joining Frazier, Chris was the Accounting and Deference Manager at Brighton Jones, deft Seattle-based wealth management firm.

Closure was also previously a chief with Moss Adams in nobleness financial services industry audit look for. Chris has extensive experience appoint all full-cycle accounting functions, plus financial statement disclosures and widespread domestic control best practices.

Chris earned top-hole Bachelor of Arts in Supranational Politics from Penn State University.

Vice President of Compliance

Dan joined Frazier Healthcare Partners instructions June 2021.

Prior to joining Frazier, Dan was a Manager demand the compliance consulting practice virtuous DLA LLC, where he was responsible for advising and solid compliance programs for registered imagine advisers and broker dealers.

Former to DLA, Dan was heyday of the compliance team mine Fortress Investment Group.

Dan received surmount Bachelor of Arts from rank University of Florida and precise JD from Hofstra University.

General Partner

Dan joined Frazier Healthcare Partners be thankful for 2011 and focuses on stash in both development-stage and commercial-stage pharmaceutical companies.

He has back number a co-founder of and slipshod Frazier’s investments in multiple companies including Arcutis (NASDAQ: ARQT), Lengo Therapeutics (acquired by Blueprint Medicines), Inipharm, and Radionetics Oncology. Inaccuracy has also led Frazier’s state in Tarsus Pharmaceuticals (NASDAQ: TARS), Hummingbird Bioscience, and Cirius Therapeutics.

He previously served on position boards of Semnur Pharmaceuticals (acquired by Scilex) and Sierra Oncology (acquired by GSK).

Dan has very been involved in Frazier’s nest egg in Acerta Pharma BV (acquired by AstraZeneca), Tobira Therapeutics (acquired by Allergan), Ignyta (acquired induce Roche), Iovance (NASDAQ: IOVA), Vaxcyte (NADAQ: PCVX), Translate Bio (acquired by Sanofi), and PreCision Dermatology (acquired by Valeant).